The Queen's Cancer Research Institute (QCRI) was established in 2001.
Research in the Institute extends from population studies of cancer etiology, through tumor biology and clinical trials, to outcomes and health services research. The Institute is committed to fostering transdisciplinary investigation of areas of cancer control that lie at the interface between fundamental, clinical and population research.
The three divisions of the Institute are presently populated by approximately 250 faculty, graduate and post-doctoral trainees and support staff. Opportunities for graduate and post-doctoral training are offered in partnership with several departments at the University, including: Biomedical & Molecular Sciences (including former departments of Anatomy & Cell Biology, Biochemistry, Microbiology & Immunology, and Pharmacology & Toxicology), Community Health & Epidemiology, Mathematics & Statistics, Oncology, Pathology & Molecular Medicine, and the Queen's School of Policy Studies.
The Institute also operates a training program in transdisciplinary cancer research, supported by the Terry Fox Foundation in partnership with the Canadian Institutes of Health Research, that is tailored to meet the needs of graduate and post-doctoral trainees from a wide range of disciplines.